Celgene to promote Alkeran
Executive Summary
Celgene will distribute and promote GSK's oncologic agent Alkeran (melphalan) under Celgene label. Alkeran, approved for palliative treatment of multiple myeloma, had sales of about $15 mil. in 2002, Celgene said...